Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...
13d
News-Medical.Net on MSNNew three-organ system offers an animal-free alternative for pharmacokinetics researchInnovative organ-on-chip specialist Dynamic42 and ESQlabs, experts in digital life sciences solutions, have successfully ...
Tracking targeted drug delivery is often a challenge due to limitations in the current imaging techniques. A recent study reports a breakthrough imaging technique that allows direct and highly ...
Tracking targeted drug delivery is often a challenge due to limitations in current imaging techniques. A recent study by ...
Drug More Than Doubles Survival Time for Glioblastoma Patients Mar. 7, 2025 — Researchers have developed a drug shown to significantly extend survival time for patients with glioblastoma ...
6don MSN
A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have ...
Noncompartmental methods were used to determine pharmacokinetic parameters ... route potentially improves systemic bioavailability of drugs since it bypasses gastrointestinal degradation and ...
Students will explore the effects of venoms, poisons, drugs and everyday chemicals on the human body, receiving expert-level instruction and hands-on training at the college’s Arizona Poison and Drug ...
Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...
EXCLUSIVE: MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain
MIRA Pharmaceuticals gains approval for a Phase 1 trial of Ketamir-2 in Israel, aiming to complete by Q4 2025 before moving ...
The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.
6d
News-Medical.Net on MSNBreakthrough drug combination targets KRAS mutation in lung cancerA breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib-an FDA-approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results